Print
Email
Print Edition StoriesFriday, December 4, 2009
Pressure Biosciences nets another $1.2M
By Mass High Tech staff
MHT's Rodney Brown: Honoring tech citizenship among companies
Funding drugs for rare diseases
MHT's Marc Songini: Technology to keep seniors healthy
Pressure Biosciences Inc. has pulled in $1.2 million through a combination of equity, warrants and securities. The securities appear to be part of a $2.5 million private placement in November, according to a filing with the U.S. Securities and Exchange Commission.
In the November regulatory filing, the South Easton-based developer of bench-top instruments using pressure cycling technology sold about $1.16 million in stock and warrants as a first tranche.
Pressure Biosciences’ (Nasdaq: PBIO) pressure cycling technology is based on varying degrees of very high pressure and low pressure, to get cells to do what science wants them to. The firm has integrated the technology into a series of the company’s bench-top products, called Barocyclers.
More about Pressure Biosciences
Prior to its most recent private placement, Pressure Biosciences last completed a $1.8 million private placement in February from the sale of 156,980 units of equity.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
